Need professional-grade analysis? Visit stockanalysis.com
$3.68B
N/A
1,402
N/A
Berry Genomics Co Ltd (000710) trades on SHE in CNY. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CNY10.06, down 2.52% from the previous close.
Over the past year, 000710 has traded between a low of CNY10.05 and a high of CNY16.61. The stock has lost 19.8% over this period. It is currently 39.4% below its 52-week high.
Berry Genomics Co Ltd has a market capitalization of $3.68B.
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services. The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company was founded in 2010 and is headquartered in Beijing, China.
Side-by-side comparison against top Healthcare peers.